The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Prevention of hepatocellular carcinoma with antiviral therapy
Di Bisceglie AM1. S Afr Med J. 2018 Aug 8;108(8b):47-50. doi: 10.7196/SAMJ.2018.v108i8b.13501.
Author information
1
Department of Internal Medicine, Saint Louis University School of Medicine, Missouri, USA. dibiscam@slu.edu.
Abstract
Chronic viral hepatitis types B and C may eventually lead to the development of hepatocellular carcinoma. Although hepatitis B is readily preventable by vaccination, there is growing evidence that antiviral therapy directed against hepatitis B may reduce the risk of liver cancer among those already infected. There is no vaccine against hepatitis C, but the evidence is now strong that antiviral therapy with sustained virological response (viral cure) reduces, but does not eliminate, the risk of hepatocellular carcinoma.